TRIZELL LTD.
17Patents
17Active
17Granted
50Portfolio score
Filing activity: Sep 9, 2016 → Feb 14, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11242504B2 | Aseptic bioreactor sampling system | Chemistry; Metallurgy | 2 | Active |
| US11261416B2 | Fixed-bed bioreactor with constant-flow pump / tubing system | Chemistry; Metallurgy | 2 | Active |
| US11932843B2 | Adherent cell culture substrate sampling device | Chemistry; Metallurgy | 1 | Active |
| US11311487B2 | Viral vector stabilization | Emerging Cross-Sectional Technologies | 1 | Active |
| US11781102B2 | Large-scale PEI-mediated plasmid transfection | Chemistry; Metallurgy | 1 | Active |
| US12178865B2 | CDKN2A companion diagnostic for bladder cancer interferon therapy | Physics | 0 | Active |
| US10829785B2 | Nucleic acid application primers | Chemistry; Metallurgy | 0 | Active |
| US12391911B2 | Adherent cell culture substrate sampling device | Chemistry; Metallurgy | 0 | Active |
| US12343395B2 | Regulatory macrophages for treating angiopathies | Chemistry; Metallurgy | 0 | Active |
| US12152281B2 | Gene therapy vector contamination assay | Chemistry; Metallurgy | 0 | Active |
| US10335461B2 | Interferon therapy | Chemistry; Metallurgy | 0 | Active |
| US11648266B2 | Regulatory macrophages for treating angiopathies | Chemistry; Metallurgy | 0 | Active |
| US12264324B2 | Viral vector assay and vector | Chemistry; Metallurgy | 0 | Active |
| US12116559B2 | Method of manufacturing a recombinant polypeptide | Chemistry; Metallurgy | 0 | Active |
| US11446249B2 | Viral vector stabilization | Emerging Cross-Sectional Technologies | 0 | Active |
| US11104915B2 | Viral vector assay and vector | Chemistry; Metallurgy | 0 | Active |
| US11547668B2 | Viral vector stabilization | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.